
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 13.150 | 13.150 | 0.000 |
Shares | 88.270 | 88.660 | 0.390 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.839 | 19.266 |
Price to Book | 3.134 | 3.030 |
Price to Sales | 3.895 | 2.636 |
Price to Cash Flow | 11.313 | 11.426 |
Dividend Yield | 0.891 | 2.154 |
5 Years Earnings Growth | 14.953 | 12.590 |
Number of long holdings: 266
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 7.50 | 112.46 | +1.81% | |
Amgen | US0311621009 | 6.93 | 290.33 | +1.13% | |
Regeneron Pharma | US75886F1075 | 6.69 | 493.22 | +2.10% | |
Vertex | US92532F1003 | 6.47 | 450.50 | +1.51% | |
AstraZeneca ADR | US0463531089 | 3.31 | 72.88 | +0.73% | |
ProShares Ultra Nasdaq Biotechnology | US74347R2141 | 2.66 | 46.75 | +3.41% | |
Alnylam | US02043Q1076 | 2.64 | 300.83 | -2.33% | |
Biogen | US09062X1037 | 1.94 | 133.13 | +2.12% | |
Illumina | US4523271090 | 1.84 | 82.66 | +0.50% | |
argenx ADR | US04016X1019 | 1.72 | 585.93 | +0.92% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF NASDAQ 100 Index Fund QDII USD | 1.94B | 0.85 | 17.18 | 15.71 | ||
GF Global Selction Eq QDII USD | 1.33B | 0.93 | 20.26 | 9.39 | ||
GF American Estate Index QDII USD | 23.04M | -0.61 | 0.68 | 3.73 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review